{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies on the tumor rejection antigen P1A—which is encoded by the X‐linked Trap1a gene and is sometimes referenced in the context of MIR5090—demonstrate its involvement in tumor immune evasion. One investigation found that although diverse tumor cell lineages shared the P1A antigen, they deployed distinct strategies to thwart adoptive T‐cell therapy. While some tumors underwent antigenic drift or loss, others, like Meth A fibrosarcomas, instead induced apoptosis of P1A‐specific T cells, thereby circumventing immune attack."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n \n \nIn a complementary study, the Trap1a gene was shown to have a critical function in early T‐cell development. Using chimeric mice, it was observed that deletion of Trap1a selectively arrested T‐cell differentiation at the DN1 stage—even though early progenitor cells still expressed key markers—indicating that Trap1a (and by association MIR5090) operates as an essential, Notch‐independent regulator of the differentiation potential of hematopoietic progenitors toward the T‐cell lineage."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n \n \nTogether, these findings suggest that the gene product associated with MIR5090 plays a multifaceted role in both cancer biology and immunology. It not only modulates mechanisms of tumor immune escape through alterations in the expression or presentation of the tumor antigen P1A but also is indispensable for the proper maturation of T cells from progenitor cells. This dual functionality underscores its significance as a potential molecular bridge between tumor immunogenicity and T‐cell developmental processes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Xue-Feng Bai, Jin-Qing Liu, Pramod S Joshi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Different lineages of P1A-expressing cancer cells use divergent modes of immune evasion for T-cell adoptive therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-06-0279"}], "href": "https://doi.org/10.1158/0008-5472.CAN-06-0279"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16912204"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16912204"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Chi-Shan Li, Fei Tang, Peng Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Trap1a is an X-linked and cell-intrinsic regulator of thymocyte development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Mol Immunol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cmi.2015.108"}], "href": "https://doi.org/10.1038/cmi.2015.108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27063468"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27063468"}]}]}]}